Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on May 27, 2025

Lightbridge Outlines Opportunities Created by President Trump's Nuclear Executive Orders

Lightbridge Outlines Opportunities Created by President Trump's Nuclear Executive Orders

RESTON, Va, May 27, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced how President Trump's recent nuclear energy Executive Orders (the “Executive …

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary

**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) …

Diamond Equity Research Releases Update Note on uCloudlink Group Inc. (NASDAQ: UCL)

Diamond Equity Research Releases Update Note on uCloudlink Group Inc. (NASDAQ: UCL)

New York, May 27, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on uCloudlink Group Inc. (NASDAQ: UCL). The update note includes information …

Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations’ Cyber Attack Surface

Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations’ Cyber Attack Surface

REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- AI-fueled attacks and hyperconnected IT environments have made threat exposure one of the most urgent cybersecurity challenges facing enterprises today. In response, Check Point® Software Technologies …

Super League Announces Exclusive Partnership with AdArcade to Bring High-Performing Native Playable™ Ads to Brands and Media Agencies at Scale Across Mobile Games

Super League Announces Exclusive Partnership with AdArcade to Bring High-Performing Native Playable™ Ads to Brands and Media Agencies at Scale Across Mobile Games

~ Expanded relationship deepens Super League’s revenue diversification through AdArcade’s patented format that outperforms standard playable ads by 3x ~ SANTA MONICA, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE), a leader in engaging …

Ascent Solar Technologies Signs Master Services Agreement to Provide NOVI Space with Rollable PV Array Blankets for Launch in 2026

Ascent Solar Technologies Signs Master Services Agreement to Provide NOVI Space with Rollable PV Array Blankets for Launch in 2026

THORNTON, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (“Ascent” or the “Company”) (Nasdaq: ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today …

Seanergy Maritime Reports Financial Results for the Quarter Ended March 31, 2025 and Declares Cash Dividend of $0.05 Per Share

Seanergy Maritime Reports Financial Results for the Quarter Ended March 31, 2025 and Declares Cash Dividend of $0.05 Per Share

Highlights   (in million USD, except EPS) Q1 2025 Q1 2024 Net Revenues $24.2 $38.3 Net (loss) / income ($6.8) $10.2 Adjusted net (loss) / income1 ($5.2) $11.6 EBITDA1 $6.6 $21.6 Adjusted EBITDA1 $8.0 $23.2       (Loss) / earnings / per share Basic …

BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique; Extends Growing List of Banking Customers

BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique; Extends Growing List of Banking Customers

LISBON, Portugal and HOLMDEL, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced a strategic …

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Cash runway extended into 2028; capital proceeds to fund operations through potential 2027 efficacy readout for LX2006 in Friedreich ataxia cardiomyopathy Financing led by Frazier Life Sciences and Janus Henderson Investors with participation from new and …

FinWise Bancorp Added to Membership of US Small-Cap Russell 2000® Index

FinWise Bancorp Added to Membership of US Small-Cap Russell 2000® Index

MURRAY, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced that it was added as a member of the US small-cap Russell 2000® Index, effective after …

Nexxen Announced as a Preliminary Addition to the Russell 3000 Index

Nexxen Announced as a Preliminary Addition to the Russell 3000 Index

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has been named a …

Purpose Investments Inc. Announces Final May 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

Purpose Investments Inc. Announces Final May 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. announced today the final May 2025 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund. The …

Purpose Investments Inc. annonce le taux de distribution final de mai 2025 Fonds d’épargne à intérêt élevé Purpose, Fonds de trésorerie américain Purpose, Fonds de gestion de trésorerie Purpose et Fonds de trésorerie américain Purpose

Purpose Investments Inc. annonce le taux de distribution final de mai 2025 Fonds d’épargne à intérêt élevé Purpose, Fonds de trésorerie américain Purpose, Fonds de gestion de trésorerie Purpose et Fonds de trésorerie américain Purpose

TORONTO, 27 mai 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. a annoncé aujourd’hui les taux de distribution définitifs d'avril 2025 pour le Fonds d’épargne à intérêt élevé Purpose, le Fonds de trésorerie en dollars américains Purpose, le Fonds de …

NETCLASS TECHNOLOGY INC. and East China Normal University Sign Cooperation Agreement to Pioneer a New Era of Smart Education

NETCLASS TECHNOLOGY INC. and East China Normal University Sign Cooperation Agreement to Pioneer a New Era of Smart Education

SHANGHAI and HONG KONG, May 27, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC. (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, has officially …

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 …

Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies

Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced a strategic collaboration to …

Swvl Secures 3-Year Contract Worth Up to $4 Million with a Large Enterprise in Essential Services

Swvl Secures 3-Year Contract Worth Up to $4 Million with a Large Enterprise in Essential Services

Swvl secures a 3-year contract worth up to $4 million, which it expects will exceed $5.2 million by contract expiry, which extends a longstanding relationship for a total of six years with this renewal Swvl’s services extend to provide accessibility to …

Canstar Ramps Up Critical Minerals Exploration With Initial Payment from $11.5M Strategic Exploration JV

Canstar Ramps Up Critical Minerals Exploration With Initial Payment from $11.5M Strategic Exploration JV

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- (TSXV: ROX) (OTCPK: CSRNF) Canstar Resources Inc. is ramping up critical metals exploration in Newfoundland with the receipt of the initial $500,000 tranche of its previously announced $11.5M strategic exploration …

Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions

Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions

PETAH TIKVA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Commercial Division received over $25 …

Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease

Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease

MALVERN, Pa., May 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the United States Food and Drug Administration (U.S. FDA) …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service